The University of Colorado Cancer Center contributed to one of the largest real-world analyses of small cell prostate cancer (SCPC), a rare and aggressive disease with limited treatment guidance. This study provides valuable insights into systemic therapy outcomes for SCPC, highlighting the need for further research to establish optimal treatment approaches.